Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-07-11

AUTHORS

Qunfang Zhou, Xiaohui Wang, Ruixia Li, Chenmeng Wang, Juncheng Wang, Xiaoyan Xie, Yali Li, Shaoqiang Li, Xianhai Mao, Ping Liang

ABSTRACT

BackgroundRadiofrequency ablation (RFA) is considered as a convenient treatment with mild damage in treating recurrent hepatocellular carcinoma (RHCC). However, for patients with high risk of progression after RFA still needs new strategies to decrease the repeat recurrence.MethodsA total of 460 patients with RHCC within Milan criteria in four institutions were enrolled. 174 pairs were enrolled after propensity score matching (PSM). Overall survival (OS) and tumor-free survival (TFS) were compared between the two groups. A quantitative score system was established to screen out the beneficial population from RFA–sorafenib treatment.ResultsThe 1-, 3-, and 5-year OS rates were 97.7%, 83.7%, 54.7% for RFA–sorafenib group, and 93.1%, 61.3%, 30.9% for RFA group after PSM, respectively. Compared with the RFA group, the RFA–sorafenib group had significantly better OS (P < 0.001). The 1-, 3-, and 5-year TFS rates were 90.8%, 49.0%, 20.4% for RFA–sorafenib group, and 67.8%, 28.0%, 14.5% for RFA group after PSM. The difference was observed significantly between RFA–sorafenib group and RFA group (P < 0.001). A quantitative risk score system was established to precisely screen out the beneficial population from RFA–sorafenib treatment.ConclusionsAdjuvant sorafenib after RFA was superior to RFA alone in improving survival outcomes in patients with recurrent HCC within Milan criteria after initial hepatectomy. Subgroup analyses concluded that patients with high risk score had significantly longer survival from sorafenib administration. More... »

PAGES

684-694

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00535-022-01895-3

DOI

http://dx.doi.org/10.1007/s00535-022-01895-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149378859

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35816221


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheter Ablation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propensity Score", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiofrequency Ablation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sorafenib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.414252.4", 
          "name": [
            "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Qunfang", 
        "id": "sg:person.012552570133.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012552570133.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, 410002, Changsha, Hunan Province, China", 
          "id": "http://www.grid.ac/institutes/grid.477407.7", 
          "name": [
            "Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, 410002, Changsha, Hunan Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Xiaohui", 
        "id": "sg:person.014650044322.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014650044322.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.414252.4", 
          "name": [
            "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Ruixia", 
        "id": "sg:person.015445424722.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015445424722.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.414252.4", 
          "name": [
            "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Chenmeng", 
        "id": "sg:person.016243005322.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016243005322.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Liver Surgery, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, Guangdong, China", 
          "id": "http://www.grid.ac/institutes/grid.488530.2", 
          "name": [
            "Department of Liver Surgery, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, Guangdong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Juncheng", 
        "id": "sg:person.07537734122.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07537734122.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.412615.5", 
          "name": [
            "Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xie", 
        "givenName": "Xiaoyan", 
        "id": "sg:person.0727226132.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727226132.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.414252.4", 
          "name": [
            "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Yali", 
        "id": "sg:person.011132675122.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011132675122.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, Guangdong Province, China", 
          "id": "http://www.grid.ac/institutes/grid.412615.5", 
          "name": [
            "Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, Guangdong Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Shaoqiang", 
        "id": "sg:person.01350630041.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350630041.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, 410002, Changsha, Hunan Province, China", 
          "id": "http://www.grid.ac/institutes/grid.477407.7", 
          "name": [
            "Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, 410002, Changsha, Hunan Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mao", 
        "givenName": "Xianhai", 
        "id": "sg:person.0721602757.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721602757.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.414252.4", 
          "name": [
            "Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liang", 
        "givenName": "Ping", 
        "id": "sg:person.01371123424.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371123424.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1245/s10434-020-08452-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1126644244", 
          "https://doi.org/10.1245/s10434-020-08452-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-019-07580-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1117697564", 
          "https://doi.org/10.1245/s10434-019-07580-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2014.343", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012885137", 
          "https://doi.org/10.1038/ajg.2014.343"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-019-07227-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112260119", 
          "https://doi.org/10.1245/s10434-019-07227-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00330-020-06990-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1128428039", 
          "https://doi.org/10.1007/s00330-020-06990-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-11", 
    "datePublishedReg": "2022-07-11", 
    "description": "BackgroundRadiofrequency ablation (RFA) is considered as a convenient treatment with mild damage in treating recurrent hepatocellular carcinoma (RHCC). However, for patients with high risk of progression after RFA still needs new strategies to decrease the repeat recurrence.MethodsA total of 460 patients with RHCC within Milan criteria in four institutions were enrolled. 174 pairs were enrolled after propensity score matching (PSM). Overall survival (OS) and tumor-free survival (TFS) were compared between the two groups. A quantitative score system was established to screen out the beneficial population from RFA\u2013sorafenib treatment.ResultsThe 1-, 3-, and 5-year OS rates were 97.7%, 83.7%, 54.7% for RFA\u2013sorafenib group, and 93.1%, 61.3%, 30.9% for RFA group after PSM, respectively. Compared with the RFA group, the RFA\u2013sorafenib group had significantly better OS (P\u2009<\u20090.001). The 1-, 3-, and 5-year TFS rates were 90.8%, 49.0%, 20.4% for RFA\u2013sorafenib group, and 67.8%, 28.0%, 14.5% for RFA group after PSM. The difference was observed significantly between RFA\u2013sorafenib group and RFA group (P\u2009<\u20090.001). A quantitative risk score system was established to precisely screen out the beneficial population from RFA\u2013sorafenib treatment.ConclusionsAdjuvant sorafenib after RFA was superior to RFA alone in improving survival outcomes in patients with recurrent HCC within Milan criteria after initial hepatectomy. Subgroup analyses concluded that patients with high risk score had significantly longer survival from sorafenib administration.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00535-022-01895-3", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8356870", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.8891589", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1009747", 
        "issn": [
          "0944-1174", 
          "1435-5922"
        ], 
        "name": "Journal of Gastroenterology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "57"
      }
    ], 
    "keywords": [
      "recurrent hepatocellular carcinoma", 
      "tumor-free survival", 
      "RFA group", 
      "Milan criteria", 
      "overall survival", 
      "hepatocellular carcinoma", 
      "score system", 
      "risk score system", 
      "high-risk score", 
      "quantitative score system", 
      "repeat recurrence", 
      "ResultsThe 1", 
      "initial hepatectomy", 
      "better OS", 
      "sorafenib administration", 
      "adjuvant therapy", 
      "BackgroundRadiofrequency ablation", 
      "OS rates", 
      "recurrent HCC", 
      "multicenter analysis", 
      "survival outcomes", 
      "subgroup analysis", 
      "longer survival", 
      "radiofrequency ablation", 
      "high risk", 
      "risk score", 
      "patients", 
      "propensity score", 
      "TF rate", 
      "mild damage", 
      "convenient treatment", 
      "carcinoma", 
      "survival", 
      "sorafenib", 
      "beneficial populations", 
      "treatment", 
      "RFA", 
      "scores", 
      "group", 
      "ablation", 
      "recurrence", 
      "PSM", 
      "hepatectomy", 
      "therapy", 
      "population", 
      "HCC", 
      "administration", 
      "criteria", 
      "progression", 
      "outcomes", 
      "total", 
      "risk", 
      "new strategy", 
      "rate", 
      "damage", 
      "differences", 
      "analysis", 
      "institutions", 
      "strategies", 
      "system", 
      "pairs"
    ], 
    "name": "Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis", 
    "pagination": "684-694", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149378859"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00535-022-01895-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35816221"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00535-022-01895-3", 
      "https://app.dimensions.ai/details/publication/pub.1149378859"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_955.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00535-022-01895-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00535-022-01895-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00535-022-01895-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00535-022-01895-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00535-022-01895-3'


 

This table displays all metadata directly associated to this object as RDF triples.

264 TRIPLES      21 PREDICATES      102 URIs      89 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00535-022-01895-3 schema:about N19a6dd0418bd497cb84e5916aa4059e5
2 N1dd84669586b49c5a8f470f9817b54a7
3 N2edd9b5a94184241b1ba50b4e66e28cd
4 N327c9b7297ba455b8afe7c020860aab9
5 N82f0b068a91b48c888c71f9659708d90
6 N9b0ca506ac19493abda0380ea23dbb06
7 Na406b0b5ec4e46a881067f3d8a936033
8 Ncb5f1d31086d40fd8b275c35fa90df22
9 Ndb93c5dc5d3d4bf88a5a73352c994f12
10 Ne40030840dcb496c88e736a466e99ae1
11 Nfbe9c2d298194c928ed241dc383fb3c3
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N7226710d42254143a4c2acac98422dd1
15 schema:citation sg:pub.10.1007/s00330-020-06990-8
16 sg:pub.10.1038/ajg.2014.343
17 sg:pub.10.1245/s10434-019-07227-9
18 sg:pub.10.1245/s10434-019-07580-9
19 sg:pub.10.1245/s10434-020-08452-3
20 schema:datePublished 2022-07-11
21 schema:datePublishedReg 2022-07-11
22 schema:description BackgroundRadiofrequency ablation (RFA) is considered as a convenient treatment with mild damage in treating recurrent hepatocellular carcinoma (RHCC). However, for patients with high risk of progression after RFA still needs new strategies to decrease the repeat recurrence.MethodsA total of 460 patients with RHCC within Milan criteria in four institutions were enrolled. 174 pairs were enrolled after propensity score matching (PSM). Overall survival (OS) and tumor-free survival (TFS) were compared between the two groups. A quantitative score system was established to screen out the beneficial population from RFA–sorafenib treatment.ResultsThe 1-, 3-, and 5-year OS rates were 97.7%, 83.7%, 54.7% for RFA–sorafenib group, and 93.1%, 61.3%, 30.9% for RFA group after PSM, respectively. Compared with the RFA group, the RFA–sorafenib group had significantly better OS (P < 0.001). The 1-, 3-, and 5-year TFS rates were 90.8%, 49.0%, 20.4% for RFA–sorafenib group, and 67.8%, 28.0%, 14.5% for RFA group after PSM. The difference was observed significantly between RFA–sorafenib group and RFA group (P < 0.001). A quantitative risk score system was established to precisely screen out the beneficial population from RFA–sorafenib treatment.ConclusionsAdjuvant sorafenib after RFA was superior to RFA alone in improving survival outcomes in patients with recurrent HCC within Milan criteria after initial hepatectomy. Subgroup analyses concluded that patients with high risk score had significantly longer survival from sorafenib administration.
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf Nde8a43919b77405a839f4b6a7b969195
26 Nde8fa27f9a0b4ec4a2d48fab82df0367
27 sg:journal.1009747
28 schema:keywords BackgroundRadiofrequency ablation
29 HCC
30 Milan criteria
31 OS rates
32 PSM
33 RFA
34 RFA group
35 ResultsThe 1
36 TF rate
37 ablation
38 adjuvant therapy
39 administration
40 analysis
41 beneficial populations
42 better OS
43 carcinoma
44 convenient treatment
45 criteria
46 damage
47 differences
48 group
49 hepatectomy
50 hepatocellular carcinoma
51 high risk
52 high-risk score
53 initial hepatectomy
54 institutions
55 longer survival
56 mild damage
57 multicenter analysis
58 new strategy
59 outcomes
60 overall survival
61 pairs
62 patients
63 population
64 progression
65 propensity score
66 quantitative score system
67 radiofrequency ablation
68 rate
69 recurrence
70 recurrent HCC
71 recurrent hepatocellular carcinoma
72 repeat recurrence
73 risk
74 risk score
75 risk score system
76 score system
77 scores
78 sorafenib
79 sorafenib administration
80 strategies
81 subgroup analysis
82 survival
83 survival outcomes
84 system
85 therapy
86 total
87 treatment
88 tumor-free survival
89 schema:name Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis
90 schema:pagination 684-694
91 schema:productId N301eb3cadab243da9cd61764be121608
92 N7b5d4974ce77451cae7beb970fcf74d2
93 N86748359be3f4a94a561cc1bb4d3212d
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149378859
95 https://doi.org/10.1007/s00535-022-01895-3
96 schema:sdDatePublished 2022-12-01T06:45
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher Nfbb4a56375d74162bfbcc1ddfd4594ab
99 schema:url https://doi.org/10.1007/s00535-022-01895-3
100 sgo:license sg:explorer/license/
101 sgo:sdDataset articles
102 rdf:type schema:ScholarlyArticle
103 N10a5b5e878714cbdbfbb7bd062a80323 rdf:first sg:person.0721602757.13
104 rdf:rest N58681ba79ecb48ec9a8b2836389e30e2
105 N19a6dd0418bd497cb84e5916aa4059e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Neoplasm Recurrence, Local
107 rdf:type schema:DefinedTerm
108 N1dd84669586b49c5a8f470f9817b54a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Treatment Outcome
110 rdf:type schema:DefinedTerm
111 N2a5cf738fd7c4ad19b522639805e9bb3 rdf:first sg:person.07537734122.23
112 rdf:rest N463361471259491dbafac3be7366bc90
113 N2edd9b5a94184241b1ba50b4e66e28cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Liver Neoplasms
115 rdf:type schema:DefinedTerm
116 N301eb3cadab243da9cd61764be121608 schema:name pubmed_id
117 schema:value 35816221
118 rdf:type schema:PropertyValue
119 N327c9b7297ba455b8afe7c020860aab9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Catheter Ablation
121 rdf:type schema:DefinedTerm
122 N375d1a2f971c4cabb0ef8ea1c1947ab5 rdf:first sg:person.011132675122.02
123 rdf:rest Nab5b8754740e4be7b6ff53b6f5b0eecb
124 N463361471259491dbafac3be7366bc90 rdf:first sg:person.0727226132.05
125 rdf:rest N375d1a2f971c4cabb0ef8ea1c1947ab5
126 N58681ba79ecb48ec9a8b2836389e30e2 rdf:first sg:person.01371123424.03
127 rdf:rest rdf:nil
128 N7226710d42254143a4c2acac98422dd1 rdf:first sg:person.012552570133.02
129 rdf:rest N876f354923884f81ae0bfd1788a2d0c5
130 N7b5d4974ce77451cae7beb970fcf74d2 schema:name dimensions_id
131 schema:value pub.1149378859
132 rdf:type schema:PropertyValue
133 N82f0b068a91b48c888c71f9659708d90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N86748359be3f4a94a561cc1bb4d3212d schema:name doi
137 schema:value 10.1007/s00535-022-01895-3
138 rdf:type schema:PropertyValue
139 N876f354923884f81ae0bfd1788a2d0c5 rdf:first sg:person.014650044322.14
140 rdf:rest N8dcbe458e3a4413b87b38995a3358295
141 N8dcbe458e3a4413b87b38995a3358295 rdf:first sg:person.015445424722.00
142 rdf:rest Ncc961890a8af4aa1a086aefc4caa84e4
143 N9b0ca506ac19493abda0380ea23dbb06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Sorafenib
145 rdf:type schema:DefinedTerm
146 Na406b0b5ec4e46a881067f3d8a936033 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Hepatectomy
148 rdf:type schema:DefinedTerm
149 Nab5b8754740e4be7b6ff53b6f5b0eecb rdf:first sg:person.01350630041.33
150 rdf:rest N10a5b5e878714cbdbfbb7bd062a80323
151 Ncb5f1d31086d40fd8b275c35fa90df22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Carcinoma, Hepatocellular
153 rdf:type schema:DefinedTerm
154 Ncc961890a8af4aa1a086aefc4caa84e4 rdf:first sg:person.016243005322.48
155 rdf:rest N2a5cf738fd7c4ad19b522639805e9bb3
156 Ndb93c5dc5d3d4bf88a5a73352c994f12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Retrospective Studies
158 rdf:type schema:DefinedTerm
159 Nde8a43919b77405a839f4b6a7b969195 schema:volumeNumber 57
160 rdf:type schema:PublicationVolume
161 Nde8fa27f9a0b4ec4a2d48fab82df0367 schema:issueNumber 9
162 rdf:type schema:PublicationIssue
163 Ne40030840dcb496c88e736a466e99ae1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Propensity Score
165 rdf:type schema:DefinedTerm
166 Nfbb4a56375d74162bfbcc1ddfd4594ab schema:name Springer Nature - SN SciGraph project
167 rdf:type schema:Organization
168 Nfbe9c2d298194c928ed241dc383fb3c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Radiofrequency Ablation
170 rdf:type schema:DefinedTerm
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
175 schema:name Oncology and Carcinogenesis
176 rdf:type schema:DefinedTerm
177 sg:grant.8356870 http://pending.schema.org/fundedItem sg:pub.10.1007/s00535-022-01895-3
178 rdf:type schema:MonetaryGrant
179 sg:grant.8891589 http://pending.schema.org/fundedItem sg:pub.10.1007/s00535-022-01895-3
180 rdf:type schema:MonetaryGrant
181 sg:journal.1009747 schema:issn 0944-1174
182 1435-5922
183 schema:name Journal of Gastroenterology
184 schema:publisher Springer Nature
185 rdf:type schema:Periodical
186 sg:person.011132675122.02 schema:affiliation grid-institutes:grid.414252.4
187 schema:familyName Li
188 schema:givenName Yali
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011132675122.02
190 rdf:type schema:Person
191 sg:person.012552570133.02 schema:affiliation grid-institutes:grid.414252.4
192 schema:familyName Zhou
193 schema:givenName Qunfang
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012552570133.02
195 rdf:type schema:Person
196 sg:person.01350630041.33 schema:affiliation grid-institutes:grid.412615.5
197 schema:familyName Li
198 schema:givenName Shaoqiang
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350630041.33
200 rdf:type schema:Person
201 sg:person.01371123424.03 schema:affiliation grid-institutes:grid.414252.4
202 schema:familyName Liang
203 schema:givenName Ping
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371123424.03
205 rdf:type schema:Person
206 sg:person.014650044322.14 schema:affiliation grid-institutes:grid.477407.7
207 schema:familyName Wang
208 schema:givenName Xiaohui
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014650044322.14
210 rdf:type schema:Person
211 sg:person.015445424722.00 schema:affiliation grid-institutes:grid.414252.4
212 schema:familyName Li
213 schema:givenName Ruixia
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015445424722.00
215 rdf:type schema:Person
216 sg:person.016243005322.48 schema:affiliation grid-institutes:grid.414252.4
217 schema:familyName Wang
218 schema:givenName Chenmeng
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016243005322.48
220 rdf:type schema:Person
221 sg:person.0721602757.13 schema:affiliation grid-institutes:grid.477407.7
222 schema:familyName Mao
223 schema:givenName Xianhai
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721602757.13
225 rdf:type schema:Person
226 sg:person.0727226132.05 schema:affiliation grid-institutes:grid.412615.5
227 schema:familyName Xie
228 schema:givenName Xiaoyan
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727226132.05
230 rdf:type schema:Person
231 sg:person.07537734122.23 schema:affiliation grid-institutes:grid.488530.2
232 schema:familyName Wang
233 schema:givenName Juncheng
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07537734122.23
235 rdf:type schema:Person
236 sg:pub.10.1007/s00330-020-06990-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128428039
237 https://doi.org/10.1007/s00330-020-06990-8
238 rdf:type schema:CreativeWork
239 sg:pub.10.1038/ajg.2014.343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012885137
240 https://doi.org/10.1038/ajg.2014.343
241 rdf:type schema:CreativeWork
242 sg:pub.10.1245/s10434-019-07227-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112260119
243 https://doi.org/10.1245/s10434-019-07227-9
244 rdf:type schema:CreativeWork
245 sg:pub.10.1245/s10434-019-07580-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1117697564
246 https://doi.org/10.1245/s10434-019-07580-9
247 rdf:type schema:CreativeWork
248 sg:pub.10.1245/s10434-020-08452-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1126644244
249 https://doi.org/10.1245/s10434-020-08452-3
250 rdf:type schema:CreativeWork
251 grid-institutes:grid.412615.5 schema:alternateName Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, Guangdong Province, China
252 Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, China
253 schema:name Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, Guangdong Province, China
254 Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, 510060, Guangzhou, China
255 rdf:type schema:Organization
256 grid-institutes:grid.414252.4 schema:alternateName Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China
257 schema:name Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, China
258 rdf:type schema:Organization
259 grid-institutes:grid.477407.7 schema:alternateName Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, 410002, Changsha, Hunan Province, China
260 schema:name Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, 410002, Changsha, Hunan Province, China
261 rdf:type schema:Organization
262 grid-institutes:grid.488530.2 schema:alternateName Department of Liver Surgery, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, Guangdong, China
263 schema:name Department of Liver Surgery, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, Guangdong, China
264 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...